lifestyle.brownplanet.com

Author: NewAmsterdam Pharma N.V.

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 1, 2026
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results

April 21, 2026
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

April 17, 2026
NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference

April 8, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 2, 2026
Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

April 2, 2026
Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant

March 26, 2026
NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session

March 23, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 13, 2026
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March

March 12, 2026